Dr Amy Harding: 'Modelling the ECM in head and neck cancers - from scaffold to saboteur'
- Debbie Horne, Liverpool Head and Neck Centre Manager
- Admission: Free. Registration not required.
- Online location
Add this event to my calendar
Click on "Create a calendar file" and your browser will download a .ics file for this event.
Microsoft Outlook: Download the file, double-click it to open it in Outlook, then click on "Save & Close" to save it to your calendar. If that doesn't work go into Outlook, click on the File tab, then on Open & Export, then Open Calendar. Select your .ics file then click on "Save & Close".
Google Calendar: download the file, then go into your calendar. On the left where it says "Other calendars" click on the arrow icon and then click on Import calendar. Click on Browse and select the .ics file, then click on Import.
Apple Calendar: The file may open automatically with an option to save it to your calendar. If not, download the file, then you can either drag it to Calendar or import the file by going to File >Import > Import and choosing the .ics file.
Furthering this interest into stromal cancer cell biology, her doctoral degree focussed on the role of extracellular matrix in OSCC using complex in vitro models (awarded 2020). After several post-doctoral positions in epithelial tissue-engineering and oral drug delivery she has recently joined the University of Liverpool's Liverpool Head and Neck Cancer centre as a North-West Cancer Research Senior Fellow mentored by Professor Keith Hunter, where she will be utilising her specialism to generate 3D/4D tissue-engineered models of the oral tumour microenvironment.
These models will use the extracellular matrix generated natively from patient stromal cells i.e. Cancer associated fibroblasts and mimic the protein complexities of native tumours acting as invaluable tools for understanding how the matrix progresses head and neck cancers.
Future research intends to draw on this understanding of stromal biology as well as her specialised knowledge of in vitro oral drug delivery systems to explore and exploit cancer desmoplasia. The aim being that understanding the biochemical and architectural changes that occur in the extracellular matrix of head & neck cancers, will help develop innovative and personalised stromal-targeted therapies.